先瑞达医疗(06669) - 2023 - 年度业绩

Peijia Medical Technology (Holdings) Limited 2022 Annual Report Supplemental Announcement This supplemental announcement provides additional details regarding the company's restricted share unit and share award schemes for the year ended December 31, 2022 Background and Purpose of the Announcement This announcement supplements Peijia Medical Technology (Holdings) Limited's 2022 annual report, providing additional details on the company's restricted share unit and share award schemes - This announcement is a supplement to Peijia Medical Technology (Holdings) Limited's annual report for the year ended December 31, 2022, published on April 24, 2023[2] - The supplementary content primarily concerns information related to the company's restricted share unit scheme and share award scheme[2] Changes in Restricted Share Unit Scheme During the reporting period, changes occurred in the company's restricted share unit scheme, primarily involving forfeiture of shares due to employee resignations Changes in Restricted Share Unit Scheme (During Reporting Period) | Grantees | Cancelled during reporting period (shares) | Lapsed during reporting period (shares) | Forfeited during reporting period (shares) | | :------------ | :----------------------------------------- | :-------------------------------------- | :----------------------------------------- | | 55 Employees | | 60,000 | (See attached) | | Two Employees | | N/A | | | Nine Employees | | N/A | | | Total | | 60,000 | | - Due to the resignation of certain grantees (55 employees) from the company, 60,000 restricted shares were forfeited[3] Details of Share Award Scheme The share award scheme aims to incentivize employees and directors contributing to the group, defining eligibility and the scheme's effective duration Participant Eligibility Eligibility for the share award scheme extends to employees and directors who have contributed or are expected to contribute to the group - Participants include full-time or part-time employees and directors of any member company within the group, provided the Board or authorized persons, at their sole discretion, deem they have contributed or will contribute to the group[4] - Individuals are ineligible if local laws and regulations prohibit the grant, acceptance, or vesting of awards, or if the Board determines that compliance would lead to exclusion[4] Remaining Term of the Scheme The share award scheme's validity extends for ten years from its adoption date, with approximately nine years remaining at the reporting period end - The share award scheme is effective and valid from its adoption date until the business day immediately preceding the tenth anniversary of the adoption date[5] - As of the end of the reporting period, the remaining term of the share award scheme is approximately nine years[5] Other Information and Board Composition This supplemental announcement's additional information does not alter other content in the annual report and lists the Board of Directors as of the announcement date - The additional information contained in this announcement does not affect other information in the annual report, and all other information in the annual report remains unchanged[5] - The announcement lists the Executive Directors (Ms. LI Jing, Mr. Silvio Rudolf SCHAFFNER), Non-executive Directors (Mr. Arthur Crosswell BUTCHER, Ms. June CHANG), and Independent Non-executive Directors (Dr. WANG Yuqi, Ms. NI Hong, Ms. PAN Jianer) as of the announcement date[5]